| Dr David William Azar, MD | |
|
835 Hospital Rd, Dept Of Pathology, Indiana, PA 15701-3629 | |
| (724) 471-1587 | |
| (724) 351-1417 |
| Full Name | Dr David William Azar |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 18 Years |
| Location | 835 Hospital Rd, Indiana, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093073033 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZC0500X | Pathology - Cytopathology | MD445391 (Pennsylvania) | Secondary |
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | MD445391 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Meadville Medical Center | Meadville, PA | Hospital |
| Titusville Hospital | Titusville, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Meadville Medical Center | 4284535790 | 98 |
| Titusville Area Hospital | 8022907575 | 60 |
News Archive
RaySearch Laboratories AB announces today that the license agreement with Varian Medical Systems has been restructured to add one new product, strengthen the collaborative product development efforts, and make it easier to add new capabilities and features to Varian's Eclipse™ treatment planning system. Eclipse software currently incorporates three RaySearch developments, including tools for biological evaluation, biological optimization, and conformal optimization.
Newly discovered genetic variations may help predict breast cancer risk in women who receive preventive breast cancer therapy with the selective estrogen receptor modulator drugs tamoxifen and raloxifene, a Mayo Clinic-led study has found. The study is published in the journal Cancer Discovery.
Insurers are reducing payments to medical practices in many of the plans they sell through the new health-law marketplaces, raising concerns that enrollees will have fewer doctors to choose from if low fees spark an exodus. Meanwhile, The Los Angeles Times reports that the success of the law depends in part on the actions of insurance companies, doctor groups and hospitals, all of whom are financially vested in it.
Several physician-owned specialty hospitals in the states of four Senate Appropriations Committee Democrats would benefit from an amendment to a supplemental war appropriations bill (HR 2642) that would allow the facilities to continue participating in Medicare and Medicaid, CQ Today reports.
Now, a new study published on the medRxiv* preprint server proposes a rapid method to identify the mutations in B.1.1.7 (N501Y mutation and H69/V70 deletion) and the impact of this variant on various biomarkers in hospitalized patients. This is the first study that correlates the biomarker levels to SARS-CoV-2 variants.
› Verified 6 days ago
| Entity Name | University Of Pittsburgh Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619935004 PECOS PAC ID: 8729990239 Enrollment ID: O20040308000883 |
News Archive
RaySearch Laboratories AB announces today that the license agreement with Varian Medical Systems has been restructured to add one new product, strengthen the collaborative product development efforts, and make it easier to add new capabilities and features to Varian's Eclipse™ treatment planning system. Eclipse software currently incorporates three RaySearch developments, including tools for biological evaluation, biological optimization, and conformal optimization.
Newly discovered genetic variations may help predict breast cancer risk in women who receive preventive breast cancer therapy with the selective estrogen receptor modulator drugs tamoxifen and raloxifene, a Mayo Clinic-led study has found. The study is published in the journal Cancer Discovery.
Insurers are reducing payments to medical practices in many of the plans they sell through the new health-law marketplaces, raising concerns that enrollees will have fewer doctors to choose from if low fees spark an exodus. Meanwhile, The Los Angeles Times reports that the success of the law depends in part on the actions of insurance companies, doctor groups and hospitals, all of whom are financially vested in it.
Several physician-owned specialty hospitals in the states of four Senate Appropriations Committee Democrats would benefit from an amendment to a supplemental war appropriations bill (HR 2642) that would allow the facilities to continue participating in Medicare and Medicaid, CQ Today reports.
Now, a new study published on the medRxiv* preprint server proposes a rapid method to identify the mutations in B.1.1.7 (N501Y mutation and H69/V70 deletion) and the impact of this variant on various biomarkers in hospitalized patients. This is the first study that correlates the biomarker levels to SARS-CoV-2 variants.
› Verified 6 days ago
| Entity Name | S Wilson Diagnostic Pathology Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043347297 PECOS PAC ID: 6204931835 Enrollment ID: O20070410000421 |
News Archive
RaySearch Laboratories AB announces today that the license agreement with Varian Medical Systems has been restructured to add one new product, strengthen the collaborative product development efforts, and make it easier to add new capabilities and features to Varian's Eclipse™ treatment planning system. Eclipse software currently incorporates three RaySearch developments, including tools for biological evaluation, biological optimization, and conformal optimization.
Newly discovered genetic variations may help predict breast cancer risk in women who receive preventive breast cancer therapy with the selective estrogen receptor modulator drugs tamoxifen and raloxifene, a Mayo Clinic-led study has found. The study is published in the journal Cancer Discovery.
Insurers are reducing payments to medical practices in many of the plans they sell through the new health-law marketplaces, raising concerns that enrollees will have fewer doctors to choose from if low fees spark an exodus. Meanwhile, The Los Angeles Times reports that the success of the law depends in part on the actions of insurance companies, doctor groups and hospitals, all of whom are financially vested in it.
Several physician-owned specialty hospitals in the states of four Senate Appropriations Committee Democrats would benefit from an amendment to a supplemental war appropriations bill (HR 2642) that would allow the facilities to continue participating in Medicare and Medicaid, CQ Today reports.
Now, a new study published on the medRxiv* preprint server proposes a rapid method to identify the mutations in B.1.1.7 (N501Y mutation and H69/V70 deletion) and the impact of this variant on various biomarkers in hospitalized patients. This is the first study that correlates the biomarker levels to SARS-CoV-2 variants.
› Verified 6 days ago
| Entity Name | Advanced Diagnostic Pathology Associates, Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629141874 PECOS PAC ID: 5890890685 Enrollment ID: O20070424000447 |
News Archive
RaySearch Laboratories AB announces today that the license agreement with Varian Medical Systems has been restructured to add one new product, strengthen the collaborative product development efforts, and make it easier to add new capabilities and features to Varian's Eclipse™ treatment planning system. Eclipse software currently incorporates three RaySearch developments, including tools for biological evaluation, biological optimization, and conformal optimization.
Newly discovered genetic variations may help predict breast cancer risk in women who receive preventive breast cancer therapy with the selective estrogen receptor modulator drugs tamoxifen and raloxifene, a Mayo Clinic-led study has found. The study is published in the journal Cancer Discovery.
Insurers are reducing payments to medical practices in many of the plans they sell through the new health-law marketplaces, raising concerns that enrollees will have fewer doctors to choose from if low fees spark an exodus. Meanwhile, The Los Angeles Times reports that the success of the law depends in part on the actions of insurance companies, doctor groups and hospitals, all of whom are financially vested in it.
Several physician-owned specialty hospitals in the states of four Senate Appropriations Committee Democrats would benefit from an amendment to a supplemental war appropriations bill (HR 2642) that would allow the facilities to continue participating in Medicare and Medicaid, CQ Today reports.
Now, a new study published on the medRxiv* preprint server proposes a rapid method to identify the mutations in B.1.1.7 (N501Y mutation and H69/V70 deletion) and the impact of this variant on various biomarkers in hospitalized patients. This is the first study that correlates the biomarker levels to SARS-CoV-2 variants.
› Verified 6 days ago
| Entity Name | Meadville Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629633573 PECOS PAC ID: 4284535790 Enrollment ID: O20190807000485 |
News Archive
RaySearch Laboratories AB announces today that the license agreement with Varian Medical Systems has been restructured to add one new product, strengthen the collaborative product development efforts, and make it easier to add new capabilities and features to Varian's Eclipse™ treatment planning system. Eclipse software currently incorporates three RaySearch developments, including tools for biological evaluation, biological optimization, and conformal optimization.
Newly discovered genetic variations may help predict breast cancer risk in women who receive preventive breast cancer therapy with the selective estrogen receptor modulator drugs tamoxifen and raloxifene, a Mayo Clinic-led study has found. The study is published in the journal Cancer Discovery.
Insurers are reducing payments to medical practices in many of the plans they sell through the new health-law marketplaces, raising concerns that enrollees will have fewer doctors to choose from if low fees spark an exodus. Meanwhile, The Los Angeles Times reports that the success of the law depends in part on the actions of insurance companies, doctor groups and hospitals, all of whom are financially vested in it.
Several physician-owned specialty hospitals in the states of four Senate Appropriations Committee Democrats would benefit from an amendment to a supplemental war appropriations bill (HR 2642) that would allow the facilities to continue participating in Medicare and Medicaid, CQ Today reports.
Now, a new study published on the medRxiv* preprint server proposes a rapid method to identify the mutations in B.1.1.7 (N501Y mutation and H69/V70 deletion) and the impact of this variant on various biomarkers in hospitalized patients. This is the first study that correlates the biomarker levels to SARS-CoV-2 variants.
› Verified 6 days ago
| Entity Name | Titusville Area Hospital |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1164149811 PECOS PAC ID: 8022907575 Enrollment ID: O20230321002746 |
News Archive
RaySearch Laboratories AB announces today that the license agreement with Varian Medical Systems has been restructured to add one new product, strengthen the collaborative product development efforts, and make it easier to add new capabilities and features to Varian's Eclipse™ treatment planning system. Eclipse software currently incorporates three RaySearch developments, including tools for biological evaluation, biological optimization, and conformal optimization.
Newly discovered genetic variations may help predict breast cancer risk in women who receive preventive breast cancer therapy with the selective estrogen receptor modulator drugs tamoxifen and raloxifene, a Mayo Clinic-led study has found. The study is published in the journal Cancer Discovery.
Insurers are reducing payments to medical practices in many of the plans they sell through the new health-law marketplaces, raising concerns that enrollees will have fewer doctors to choose from if low fees spark an exodus. Meanwhile, The Los Angeles Times reports that the success of the law depends in part on the actions of insurance companies, doctor groups and hospitals, all of whom are financially vested in it.
Several physician-owned specialty hospitals in the states of four Senate Appropriations Committee Democrats would benefit from an amendment to a supplemental war appropriations bill (HR 2642) that would allow the facilities to continue participating in Medicare and Medicaid, CQ Today reports.
Now, a new study published on the medRxiv* preprint server proposes a rapid method to identify the mutations in B.1.1.7 (N501Y mutation and H69/V70 deletion) and the impact of this variant on various biomarkers in hospitalized patients. This is the first study that correlates the biomarker levels to SARS-CoV-2 variants.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David William Azar, MD 835 Hospital Rd, Dept Of Pathology, Indiana, PA 15701-3629 Ph: (724) 471-1587 | Dr David William Azar, MD 835 Hospital Rd, Dept Of Pathology, Indiana, PA 15701-3629 Ph: (724) 471-1587 |
News Archive
RaySearch Laboratories AB announces today that the license agreement with Varian Medical Systems has been restructured to add one new product, strengthen the collaborative product development efforts, and make it easier to add new capabilities and features to Varian's Eclipse™ treatment planning system. Eclipse software currently incorporates three RaySearch developments, including tools for biological evaluation, biological optimization, and conformal optimization.
Newly discovered genetic variations may help predict breast cancer risk in women who receive preventive breast cancer therapy with the selective estrogen receptor modulator drugs tamoxifen and raloxifene, a Mayo Clinic-led study has found. The study is published in the journal Cancer Discovery.
Insurers are reducing payments to medical practices in many of the plans they sell through the new health-law marketplaces, raising concerns that enrollees will have fewer doctors to choose from if low fees spark an exodus. Meanwhile, The Los Angeles Times reports that the success of the law depends in part on the actions of insurance companies, doctor groups and hospitals, all of whom are financially vested in it.
Several physician-owned specialty hospitals in the states of four Senate Appropriations Committee Democrats would benefit from an amendment to a supplemental war appropriations bill (HR 2642) that would allow the facilities to continue participating in Medicare and Medicaid, CQ Today reports.
Now, a new study published on the medRxiv* preprint server proposes a rapid method to identify the mutations in B.1.1.7 (N501Y mutation and H69/V70 deletion) and the impact of this variant on various biomarkers in hospitalized patients. This is the first study that correlates the biomarker levels to SARS-CoV-2 variants.
› Verified 6 days ago
Mrs. Seshu Mahidhara, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 835 Hospital Rd, Indiana, PA 15701 Phone: 724-357-7169 Fax: 724-357-7481 | |
Dr. Steven Patrick Griffin, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: Hospital Road, Indiana Regional Medical Center, Indiana, PA 15701 Phone: 724-357-7169 Fax: 724-357-7481 | |
Dr. Stanley J Geyer, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 835 Hospital Rd, Indiana, PA 15701 Phone: 724-357-7169 Fax: 724-357-7481 | |
Steven H Wilson, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 835 Hospital Rd, Indiana, PA 15701 Phone: 800-343-7123 Fax: 412-937-5710 |